about
Clinical applications of squamous cell carcinoma antigen-immunoglobulins M to monitor chronic hepatitis COncostatin M mediates STAT3-dependent intestinal epithelial restitution via increased cell proliferation, decreased apoptosis and upregulation of SERPIN family membersIgM-linked SerpinB3 and SerpinB4 in sera of patients with chronic liver diseaseSerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancerSquamous cell carcinoma antigen (SCCA) is up-regulated during Barrett's carcinogenesis and predicts esophageal adenocarcinoma resistance to neoadjuvant chemotherapySERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.SerpinB3 Promotes Pro-fibrogenic Responses in Activated Hepatic Stellate Cells.Quantitative proteomic study of human lung squamous carcinoma and normal bronchial epithelial acquired by laser capture microdissectionSCCA1/SERPINB3 promotes oncogenesis and epithelial-mesenchymal transition via the unfolded protein response and IL6 signalingSERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3).SERPINB3 in the chicken model of ovarian cancer: a prognostic factor for platinum resistance and survival in patients with epithelial ovarian cancer.Hepatic progenitor cells express SerpinB3Systems-level effects of ectopic galectin-7 reconstitution in cervical cancer and its microenvironment.Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold NanoparticlesSerpinB3 and Yap Interplay Increases Myc Oncogenic Activity.SERPINB3 is associated with longer survival in transgenic mice.SERPINB3 and B4: From biochemistry to biologyProteomics approach to identify novel metastatic bone markers from the secretome of PC-3 prostate cancer cells.Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells.SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I.HCV genotype 3 and squamous cell carcinoma antigen (SCCA)-IgM are independently associated with histological features of NASH in HCV-infected patients.Circulating SCCA-IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients.Identification of altered protein abundances in cholesteatoma matrix via mass spectrometry-based proteomic analysis.SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection.Combined detection of Twist1, Snail1 and squamous cell carcinoma antigen for the prognostic evaluation of invasion and metastasis in cervical squamous cell carcinoma.Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure.Proteome analysis reveals antiangiogenic environments in chronic wounds of diabetes mellitus type 2 patients.Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging Biomarker for Skin Inflammatory Diseases.Network-based association analysis to infer new disease-gene relationships using large-scale protein interactions.
P2860
Q26774517-BBD3B81B-5327-491F-AA33-B6AB9A70F9ACQ28542037-C55B5F8E-7F74-47AD-85DA-479680A7BF1EQ28727095-F2B3E983-DE88-4F31-A056-F3342020AC08Q30842687-157098B2-5C46-4A62-8266-453986104AF4Q33648496-A9A634CB-079C-48F9-89E5-D0A0341A17D1Q33683019-9A9F601E-FE66-48F6-BD29-EFD7BA00B523Q33794042-614E8E0A-EDF6-464C-9FA2-D9042FCB5F02Q34231602-45E20E23-E627-4000-845C-2428EF3B3EC4Q34438487-6809218A-EF78-4BF7-9B2E-CE6F0B0D1B42Q34476786-A59EB84B-C5B9-475B-9575-CA4903CE0967Q34490605-46749E4E-2DD0-4A55-9031-55B43C5A5681Q35092061-2736A027-539A-4474-8A00-D61AD9F6915CQ36112218-FE97A136-E2CD-4269-97A3-2BB74262CCE8Q36172428-FA0BDEB2-A7A3-47C1-AD1C-9015C661EF1EQ36346439-F1CFE290-F9CE-49D6-9E9C-1CE498D6C3ACQ37256580-EC161836-65D4-4C74-98D3-1926618FE717Q37653336-8B8BBA89-26D4-423E-A291-E23802C2029BQ38699865-D5AD6D18-15BF-4A2C-BA19-B83EDC8E7DB0Q38924905-E1EF4A39-008E-4DB6-89BD-4B593D6B42CFQ40720441-BBB52DC1-8D6A-4336-8165-F0AEF66E8363Q41528078-5AE444C9-629E-4A9F-86F6-EEBC42BF1F43Q42510932-3E94DE64-8145-4C33-9B84-B3198CF618D5Q43154464-A25C4EC0-1A05-4DD7-9978-DF615F1BEB73Q45355954-98F1BADE-D36D-494A-889D-122D6005A64AQ47590477-0DCA96F3-7F05-4187-8117-FCEC12CABCD9Q48192189-7B33BD9A-3151-4C2E-A6EC-49D972D86557Q50880864-95A01CE8-7692-433E-A881-3683629CC714Q52593722-5495921C-71F5-4173-B6C3-430FBF4275E0Q55492382-DE524872-A70B-42CC-8FF5-FAECAC49941F
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
SERPINB3 induces epithelial-mesenchymal transition
@ast
SERPINB3 induces epithelial-mesenchymal transition
@en
SERPINB3 induces epithelial-mesenchymal transition
@en-gb
SERPINB3 induces epithelial-mesenchymal transition
@nl
type
label
SERPINB3 induces epithelial-mesenchymal transition
@ast
SERPINB3 induces epithelial-mesenchymal transition
@en
SERPINB3 induces epithelial-mesenchymal transition
@en-gb
SERPINB3 induces epithelial-mesenchymal transition
@nl
prefLabel
SERPINB3 induces epithelial-mesenchymal transition
@ast
SERPINB3 induces epithelial-mesenchymal transition
@en
SERPINB3 induces epithelial-mesenchymal transition
@en-gb
SERPINB3 induces epithelial-mesenchymal transition
@nl
P2093
P50
P3181
P356
P1476
SERPINB3 induces epithelial-mesenchymal transition
@en
P2093
Angelo Gatta
Fiorella Calabrese
Laura Vidalino
Mariagrazia Ruvoletto
Patrizia Pontisso
Santina Quarta
Stefania Cannito
P304
P3181
P356
10.1002/PATH.2708
P407
P577
2010-07-01T00:00:00Z